Trump Pushes MMR Split; Pharma Rejects It Within Hours

The Trump administration has called on pharmaceutical companies to break apart the combined measles-mumps-rubella vaccine into three separate shots, a move dismissed as scientifically baseless by the industry's leading trade group within hours of the recommendation. The proposal echoes long-debunked anti-vaccine claims and risks disrupting one of the most widely administered childhood immunisation schedules in the world. PhRMA, the main industry lobby, publicly rejected the idea the same day it was floated.